The Pharmacokinetics of Vancomycin Calculated Using the Sawchuk-Zaske Method in Patients Undergoing Continuous Hemodiafiltration-Reference-Cited by-同舟云学术

The Pharmacokinetics of Vancomycin Calculated Using the Sawchuk-Zaske Method in Patients Undergoing Continuous Hemodiafiltration

Published:2016 Issue:5 Volume:42 Page:328-335
ISSN:1346-342X
Container-title:Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
language:en
Short-container-title:Jpn. J. Pharm. Health Care Sci.

Author:

Morimoto Takeyori¹²,Nagashima Hiroki¹,Ozato Yasuyuki³,Morimoto Yasuko⁴,Tokuyama Shogo²

Affiliation:

1. Department of Pharmacy, Suita Tokushukai Hospital

2. Department of Clinical Pharmacy School of Pharmaceutical Sciences, Kobe Gakuin University

3. Department of Pharmacy, Yao Tokushukai General Hospital

4. Laboratory of Hygienic Chemistry and Health Support, Kobe Gakuin University

Publisher

Japanese Society of Pharmaceutical Health Care and Sciences

Subject

General Earth and Planetary Sciences,General Environmental Science

Link

https://www.jstage.jst.go.jp/article/jjphcs/42/5/42_328/_pdf

Reference14 articles.

1. 1) Matsumoto K, Takesue Y, Ohmagari N, Mochizuki T, Mikamo H, Seki M, Takakura S, Tokimatsu I, Takahashi Y, Kasahara K, Okada K, Igarashi M, Kobayashi M, Hamada Y, Kimura M, Nishi Y, Tanigawara Y, Kimura T, Practice guidelines for therapeutic drug monitoring of vancomycin: a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring, J Infect Chemother, 2013, 19, 365-380.

2. 2) Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, Kaplan SL, Karchmer AW, Levine DP, Murray BE, J Rybak M, Talan DA, Chambers HF, Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children, Clin Infect Dis, 2011, 52, 285-292.

3. 3) Gilbert DN, Chambers HF, Eliopoulos GM, Saag MS, “The Sanford Guide To Antimicrobial Therapy, 44^th Edition”, Antimicrobial Therapy Inc, Sperryville VA, 2014.

4. 4) Yamamoto T, Yasuno N, Katada S, Hisaka A, Hanafusa N, Noiri E, Yahagi N, Fujita T, Suzuki H, Proposal of a Pharmacokinetically Optimaized Dosage Regimen of Antibiotics in Patients Receiving Continuous Hemodiafiltration, Antimicrob Agents Chemother, 2011, 55, 5804-5812.

5. 5) DelDot ME, Lipman J, Tett SE, Vancomycin pharmacokinetics in critically ill patients receiving continuous venovenous haemodiafiltration, Br J Clin Pharmacol, 2004, 58, 259-268.